Solvay GmbH

CREON[R] (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis.
Gene Therapy Weekly; 11/12/2009; 1041 words; ...Affairs and Chief Medical Officer at Solvay Pharmaceuticals, Inc. "These...of Life, Regulatory Actions, Solvay Pharmaceuticals GmbH, Surgery, Treatment, U.S...Administration, Weight Loss, Solvay Pharmaceuticals Inc. This article...

CREON pancrelipase Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis.
Gene Therapy Weekly; 11/12/2009; 1039 words; ...Affairs and Chief Medical Officer at Solvay Pharmaceuticals, Inc. "These...of Life, Regulatory Actions, Solvay Pharmaceuticals GmbH, Surgery, Treatment, U.S...Administration, Weight Loss, Solvay Pharmaceuticals Inc. This article...

Videos: Solvay Pharmaceuticals, Inc. Announces Thriving Student Achiever and Awards $17K SolvayCARES(SM) Scholarship to College Student with Cystic Fibrosis.
Biotech Week; 11/11/2009; 962 words; ...role models for the CF community." Since 1993, Solvay Pharmaceuticals has donated more than $2 million...Business, Pharmaceutical Company, Pulmonology, Solvay Pharmaceuticals GmbH, Solvay Pharmaceuticals Inc. This article was prepared...

Altus Starts Phase III Studies Of Pancreatic Enzyme Product.
BIOWORLD Today; 11/3/2009; 1311 words; ...and Egypt, rights to ALTU-135 are held by Dr. Falk Pharma GmbH, of Freiburg, Germany. Lieber said the companies are "in...forward in Europe." The market currently is dominated by Creon (Solvay Pharmaceuticals Inc.), Ultrase (Axcan Pharma Inc.) and...

Other News To Note.
BIOWORLD Today; 11/3/2009; 1354 words; ...Martinsried, Germany, formed a research collaboration with Solvay Pharmaceuticals GmbH, of Brussels, Belgium, to identify new molecules...has prepared a selection of active substances that Solvay will examine in biological tests. o Angiotech Pharmaceuticals...